- 01

Eli Lilly and Company
LLYNYSEUnited States
$1.12T
+6.6% 1W·+56.6% 1Y
- 02

Johnson & Johnson (J&J)
JNJNYSEUnited States
$615.9B
-2.3% 1W·+32.3% 1Y
- 03

AbbVie Inc.
ABBVNYSEUnited States
$504.4B
+3.2% 1W·+24.3% 1Y
- 04

F. Hoffmann-La Roche AG
ROGSIXSwitzerland
$371.7B
-9.5% 1W·— 1Y
- 05

Merck & Co., Inc.
MRKNYSEUnited States
$360.1B
+0.2% 1W·+72.1% 1Y
- 06

Novartis AG
NOVNSIXSwitzerland
$286.3B
+4.7% 1W·+14.6% 1Y
- 07

AstraZeneca PLC
AZNNYSEUnited Kingdom
$256.5B
— 1W·-3.2% 1Y
- 08

Pfizer Inc.
PFENYSEUnited States
$168.6B
+4.6% 1W·— 1Y
- 09

Sanofi S.A.
SNYNYSEFrance
$97.3B
+0.6% 1W·-19.8% 1Y
- 10

Jiangsu Hengrui Pharmaceuticals
600276SSEChina
$46.4B
-0.5% 1W·-23.6% 1Y
- 11

Shanhe Pharmacaps
300452SZSEChina
$443M
-6.7% 1W·— 1Y
- 12

Tasly Pharmaceutical Group Co., Ltd.
600535SSEChina
—
— 1W·— 1Y
Showing 1–12 of 12
